I was in the room—figuratively, at least—for every argument, compromise, and consensus-building moment that produced the 2026 American Heart Association/American College of Cardiology (AHA/ACC) multisociety guideline for the evaluation and management of acute pulmonary embolism (PE) in adults.1 As one of the writing committee members, I watched an extraordinary group of clinicians spanning cardiology, interventional radiology (IR), hematology, emergency medicine, pulmonology, and other...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Mona Ranade
What’s on Your Pulmonary Embolism Trial Wishlist?
Pavan K. Kavali, MD Associate Professor of Radiology and Surgery Mallinckrodt Institute of Radiology Washington University School of Medicine St. Louis, Missouri Disclosures: Consultant to Penumbra, AngioDynamics, and Surmodics; safety review board for Nanobiotix and Advarra.
PE in Prime Time: New Pathways, Devices, and Trials
Gregory Piazza, MD, MS Director, Vascular Medicine Section Brigham and Women’s Hospital Associate Professor of Medicine Harvard Medical School Boston, Massachusetts gpiazza@partners.org Akhilesh Sista, MD, FSIR, FAHA Professor, Department of Radiology Weill Cornell Medicine New York, New York aks9010@med.cornell.edu Brent Keeling, MD Professor of Surgery Division of Cardiothoracic Surgery, Department of Surgery Emory University School of Medicine Atlanta, Georgia brent.keeling@emory.edu Saher...
Adopting New DVT Tools: What Are the Key Questions to Ask Beforehand?
Deep vein thrombosis (DVT) remains a significant global health issue, with acute cases potentially leading to severe long-term complications, such as postthrombotic syndrome (PTS).1 Current standard treatment predominantly relies on anticoagulation (AC), aimed at preventing thrombus extension and recurrence, but it often falls short in addressing residual thrombus burden, which can lead to PTS and chronic venous insufficiency in up to 50% of patients.1,2 Over the past 2 decades, technologic...
Streamlining DVT/CVO Management
Steven Abramowitz, MD Executive Director MedStar Vascular Surgery Program Chair, Department of Vascular Surgery MedStar Washington Hospital Center Associate Professor of Surgery Georgetown University Washington, DC steven.d.abramowitz@medstar.net S.
Essential Innovation and Clinical Trial Needs in Vascular Care
AORTIC Kendal M. Endicott, MD Inova Health Systems Heart and Vascular Institute Fairfax, Virginia kendal.endicott@inova.org Jessica P. Simons, MD, MPH University of Massachusetts Chan Medical School Division of Vascular and Endovascular Surgery Worcester, Massachusetts jessica.simons@umassmemorial.org The treatment of aortic aneurysms has a robust body of evidence compared to many other vascular pathologies.
Decision-Making in Submassive Pulmonary Embolism
Vladimir Lakhter, DO, FSVM Assistant Professor Temple University Hospital Lewis Katz School of Medicine Philadelphia, Pennsylvania vladimir.lakhter@tuhs.temple.edu Gerard O’Sullivan, MD Department of Interventional Radiology University College Hospital Galway, Ireland gerard.osullivan2@hse.ie Mona Ranade, MD Assistant Professor, Interventional Radiology David Geffen School of Medicine at UCLA Los Angeles, California mranade@mednet.ucla.edu Akhilesh Sista, MD, FSIR, FAHA Professor, Department...
Rationale for the APEX-AV, HI-PEITHO, and PE-TRACT Trials
Intermediate-risk (submassive) pulmonary embolism (PE) has been the subject of active clinical study over the last 8 years.
Case Report: Use of the AlphaVac System for the Removal of Right Atrial Thrombus
Right heart thrombus (RHT) presents a challenging clinical dilemma with potentially catastrophic mortality. An increasing number of devices and techniques for endovascular thrombectomy have been developed in the last 20 years with overlapping applications in treating pulmonary embolism (PE), deep vein thrombus (DVT), and RHT.1-4 RHT is typically associated with PE from DVT but may develop in situ in the setting of cardiac chamber dilatation or hypokinesis.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Mona
Contact Mona, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack